Who owns REGULUS THERAPEUTICS INC?
- Ticker: RGLS
- CUSIP Number: 75915k309
Tip: Access positions for across all investors
Analyze quarterly positions in Regulus Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Regulus Therapeutics stock
Who bought or sold REGULUS THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vivo Capital | 5.0M | $14M | 100% | Mar 2024 |
|
Federated Investors | 3.9M | $5.0M | 0% | Dec 2023 |
|
DAFNA Capital Management | 1.1M | $1.4M | 0% | Dec 2023 |
|
Vanguard Group | 286k | $367k | 0% | Dec 2023 |
|
Victory Capital Management | 272k | $348k | 17% | Dec 2023 |
|
Sarissa Capital Management | 185k | $237k | 0% | Dec 2023 |
|
Exome Asset Management | 178k | $228k | 100% | Dec 2023 |
|
Simplex Trading | 76k | $217k | 100% | Mar 2024 |
|
Citadel Advisors | 45k | $58k | 53% | Dec 2023 |
|
Commonwealth Equity Services | 18k | $22k | 0% | Dec 2023 |
|
Grimes & Company | 10k | $30k | -1% | Mar 2024 |
|
Citigroup | 2.1k | $2.7k | 100% | Dec 2023 |
|
Community Bank | 690.00 | $876.024000 | 0% | Dec 2023 |
|
UBS Group | 344.00 | $430.000000 | -16% | Dec 2023 |
|
Wells Fargo & Company | 140.00 | $186.662000 | 9% | Dec 2023 |
|
Royal Bank of Canada | 80.00 | $0 | 0% | Dec 2023 |
|
Jpmorgan Chase & Co | 29.00 | $37.001100 | 45% | Dec 2023 |
|
Bank of America Corporation | 11.00 | $13.999700 | 100% | Dec 2023 |
|
Who sold out of Regulus Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Virtu Financial | Sep 2023 | 26k | $36k |
Advisor Group Holdings | Sep 2023 | 50.00 | $68.000000 |